NCT02206555View on ClinicalTrials.gov

PrEP Demonstration Project (PRELUDE Study)

PHASE4CompletedINTERVENTIONAL
Enrollment

327

Participants

Timeline

Start Date

November 14, 2014

Primary Completion Date

November 28, 2016

Study Completion Date

December 20, 2017

Conditions
HIV
Interventions
DRUG

emtricitabine/tenofovir disoproxil fumarate

Trial Locations (5)

2000

Sydney Sexual Health Centre, Sydney

2010

Holdsworth House Medical Practice, Darlinghurst

St Vincent's Hospital HIV, Immunology and Infectious Disease Unit, Darlinghurst

2050

RPA Sexual Health, Camperdown

2150

Western Sydney Sexual Health Centre, Parramatta

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
lead

Kirby Institute

OTHER_GOV